x
 
 
 
 

About Us

BOARD OF DIRECTORS

photo team

Gwen Melincoff

Independent Member

Ms. Melincoff is a seasoned business development and venture professional with over 25 years of deal-making and management experience in the biotechnology and pharmaceutical industries. Ms. Melincoff is currently managing director at Gemini Advisors LLC, a biopharmaceutical consultancy, and an advisor to Verge Genomics, a startup drug discovery company and Agent Capital. Previously, Ms. Melincoff served as Vice President of Business Development at BTG International Inc., a UK-specialist healthcare company. Prior to BTG, Ms. Melincoff was Senior Vice President of Corporate Development at Shire Plc (acquired by Takeda). Additionally, she led the Shire Strategic Investment Group, the venture capital arm of Shire Plc. Ms. Melincoff was Vice President of Business Development at Adolor Corporation and held executive positions at Eastman Kodak for over ten years in a number of their health care companies. She serves on the board of directors of several biopharmaceutical companies, including Protalix Biotherapeutics, Inc., Collegium Pharmaceutical, Inc. and Soleno Therapeutics, Inc. and has previously served on the boards of Photocure ASA, Kamada Ltd. and Tobira Therapeutics Inc. Ms. Melincoff holds a B.S. in Biology from The George Washington University and an M.S. in Management and Health Care Administration from Pennsylvania State University.

 

 
 

 

Grants

Grants Grants Grants Grants

 

Patient Associations

Patient Associations Patient Associations Patient Associations Patient Associations

Centers of Research, Translational Science & Clinical Excellence

Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research
Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research Centers of Research
 

Interested in working with a dynamic team of research,
medical and business professionals? 

View Job opportunities